# Suboptimal Responders to Adefovir Switching to Entecavir

> **NCT00718887** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 228 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Adefovir/Entecavir

## Key facts

- **NCT ID:** NCT00718887
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-12
- **Final completion:** 2011-01
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718887, "Suboptimal Responders to Adefovir Switching to Entecavir". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00718887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*